Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy

Medical Physics

Volumn 25, Issue 1, 1998, Pages 20-28

  Li, Alexander N ^a   Eigler, Neal L ^b   Litvack, Frank ^b   Whiting, James S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Angioplasty; MCNP; Nitinol; Restenosis; Stents

Indexed keywords

MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY; STENTS;

ANGIOPLASTY; CORONARY ARTERY DISEASE; DOSE DISTRIBUTIONS; MCNP; NITINOL; PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY; RADIATION DELIVERY; RESTENOSIS;

DISEASES;

ALLOY; NICKEL; RADIOISOTOPE; TITANIUM; UNCLASSIFIED DRUG; VANADIUM 48;

ARTICLE; BRACHYTHERAPY; COMPUTER SIMULATION; CORONARY ARTERY DISEASE; HUMAN; POSITRON; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RADIOTHERAPY; RESTENOSIS; STENT; SYSTEM ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031930982     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.598164     Document Type: Article

References (55)

1. S. K. Chokshi, S Meyers, and P Abi-Mansour, "Percutaneous transluminal coronary angioplasty: ten years" experience," Prog. Cardiovasc. Dis. 30, 147-210 (1987).
2. J. S. Forrester, M Fishbein, R. H. Helfant, and J. Fagin, "A paradigm for restenosisbased on cell biology: clues for the development of new preventive therapies," J. Am. Coll. Cardiol 17, 758-769 (1991).
3. G. E. Austin, N. B. Ratliff, H. Hollman, S. Tabei, and D. F. Phillips, "Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty," J. Am. Coll. Cardiol. 6, 369-375 (1985).
4. A. W. Clowes and S. M. Schwartz, "Significance of quiescent smooth muscle migration in the injured rat carotid artery," Circ Res. 79, 1374-1375 (1989)
5. M. W. Liu, G S. Roubin, and S B. I. King, "Restenosis after coronary angioplasty: potential biological determinants and role of intimal hyperplasia," Circ. 79, 1374-1387 (1989).
6. M. Nobuyoshi, T. Kimura, and H. Ohishi, "Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients," J Am. Coll. Cardiol. 17, 433-439 (1991)
7. R. L. Geary, J. K. Williams, D. Golden, D G. Brown, M. E. Benjamin, and M. R. Adams, "Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis," Arteriosclerosis, Thrombosis & Vascular Biology 16, 34-43 (1996).
8. R. L. Wilensky, K. L. March, I. Gradus-Pizlo, G. Sandusky, N. Fineberg, and D. R. Hathaway, "Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit," Circ. 92, 2995-3005 (1996).
9. M. Haude, R. Erbel, H. Issa, and J Meyer, "Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stems," J. Am. Coll. Cardiol. 21, 26-34 (1993)
10. C. Hehrlein, M. Zimmermann, J Pill, J. Metz, W. Kubler, and E. von Hodenberg, "The role of elastic recoil after balloon angioplasty of rabbit arteries and its prevention by stent implantation," Eur. Heart. J. 15, 277-280 (1994).
11. G. S. Mintz, A. D. Pichard, K. Kent, L. F. Satler, J. J. Popma, S. C. Wong, J. A. Painter, D. Deforty, and M B Leon, "Endovascular stents reduce restenosis by eliminating geometric arterial remodeling: a serial intravascular ultrasound study," J. Am. Coll. Cardiol. 35A, 701-705 (1995)
12. S. G. Ellis, G. S. Roubin, J. Wilentz, J S Douglas, Jr., and S. B. King III, "Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty," Am Heart J. 41, 777-782 (1989)
13. C. J. Pepine, J. W. Hirshfeld, and R. G. MacDonald, "A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty," Circ. 81, 1753-1761 (1990)
14. H. B. Whitworth, G. S. Roubin, J. Hollman, B. Meier, P. P. Leimgruber, J. S. Douglas, Jr., S. B. I. King, and A. R. Gruentzig, "Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty," J Am. Coll. Cardiol. 8, 1271-1276 (1986).
15. G. J. Reis, M. E. Sipperly, C. H. McCabe, F. M. Sacks, T. M. Boucher, D. I. Silverman, D. S. Baim, W. Grossman, and R. C. Pasternak, "Randomized trial of fish oil for prevention of restenosis after coronary angioplasty," Lancet 2, 177-181 (1989).
16. E. S. Barnathan, J. S. Schwartz, and L. Taylor, "Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty," Circ. 76, 125-134 (1987).
17. D. W. Muller, S. G. Ellis, and E. J. Topol, "Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions," J. Am. Coll. Cardiol. 126 Suppl. B, 126B-131B (1991).
18. M. L. Knudtson, V. F. Flintoft, D. L. Roth, and J. L. Hansen, "Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty," J. Am. Coll. Cardiol. 15, 691-697 (1990).
19. W. R. M. Hermans, B. J. Rensing, B. H. Strauss, and P. W. Serruys, "Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a "magic bullet," Am Heart J. 122, 171-187 (1991).
20. P. W. Serruys, B. H. Strauss, K. J. Beatt et al. "Angiographic follow-up after placement of a self-expanding coronary-artery stent," N. Engl. J. Med 324, 13-17 (1991).
21. J. H. O'keefe, L V Giorgi, B. D. McCallister et al., "Does diltiazem reduce complications or restenosis after coronary angioplasty? A randomized blinded placebo-controlled trial," [Abstract] J. Am. Coll. Cardiol. 17, 196B (1991).
22. M. A. Thornton, A. R. Gruentzig, J. Hollman, S B. I. King, and J. S. Douglas, "Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study," Circ. 4, 721-727 (1984).
23. U.S Directional Coronary Atherectomy Investigator Group, "Restenosis following directional coronary atherectomy in a multicenter experience," Circ. 82 (1990).
24. R. S. Schwartz, T. M. Koval, W. D. Edwards, A R. Camrud, K. R. Bailey, K. Browne, R. E. Vlietstra, and D R. Holmes, "Effect of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury," J. Am. Coll. Cardiol. 19(5), 1106-1113 (1992).
25. A. Shefer, N. L. Eigler, J. S. Whiting, and F. I. Litvack, "Suppression of intimai proliferation after balloon angioplasty with local beta irradiation in rabbits," [Abstract] J. Am. Coll. Cardiol. 21(2), 185A (1993)
26. P. Anthony, H. Keys, and C. M. Evarts, "Prevention of heterotopic bone formation with early postoperative irradiation in high risk patients undergoing total hip arthroplasty: Comparison of 10 Gy vs. 20 Gy schedules," Int. J. Radiat. Oncol., Biol., Phys. 13, 365-369 (1986).
27. J E. Sylvester, P. Greenberg, and M. T Selch, "The use of postoperative irradiation for the prevention of heterotopic bone formation after total hip replacement," Int. J. Radiat. Oncol., Biol., Phys. 14, 471-476 (1988).
28. D. C. Ayers, C. M. Evarts, and J R. Parkinson, "The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty," J. Bone Jt. Surg., Am. Vol. 68, 1423-1430 (1986).
29. H. A. S. Van den Break and C. C J Minty, 'Radiation in the management of keloids and hypertrophic scar,' Br. J. Surg. 47, 594-605 (1959)
30. C. H. A. Inalsingh, 'An Experience in treating 501 patients with keloids,' Johns Hopkins Med. J. 134, 284-290 (1974).
31. J. J Kovalic and C. A. Perez, "Radiation therapy following keloidectomy: A 20 years experience," Int. J. Radiat. Oncol., Biol., Phys. 17, 77-80 (1989).
32. D. S. Levy, M M. Salter, and R. E. Roth, "Postoperative irradiation in the prevention of keloids," Am. J. Roentgenol 127, 509-510 (1976).
33. A. Enhamre and H Hammar, "Treatment of keloids with excision and postoperative x-ray irradiation," Dermatologica 167, 90-93 (1983).
34. T L. Borok, M. Bray, and I Sinclair, "Role of ionizing irradiation for 393 keloids," Int J. Radiat Oncol. Biol., Phys. 14, 865-870 (1988).
35. J. G. Wiedermann, C. Marboe, H. Amols, A. Schwartz, and J. Weinberger, "Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: Persistent benefit at 6-month follow-up," J. Am. Coll. Cardiol. 25(6), 1451-1456 (1995).
36. R. Waksman, K. A. Robinson, I. R. Crocker, M. B. Gravanis, G. D. Cipolla, and S. B. King III, "Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: A possible role for radiation therapy in restenosis prevention," Circ. 91, 1533-1539 (1995).
37. R Waksman, K. A. Robinson, I. R. Crocker, M. B. Gravanis, S J. Palmer, C. Wang, G. D. Cipolla, and S. B. King III, "Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries," Circ 92, 1383-1386 (1995).
38. J. R. Laird, A. J. Carter, W M Kufs, T. G Hoopes, A Farb, S H. Nott, R. E. Fischell, D. R Fischell, R. Virmani, and T. A. Fischell, "Inhibition of neointimal proliferation with low-dose irradiation from a β-particle-emitting stent," Circ. 93, 529-536 (1996).
39. R. Waksman, K. A. Robinson, I. R Crocker, C. Wang, M. B. Gravanis, G. D. Cipolla, R. A. Hillstead, and S. B. King III, "Intracoronary low-dose β-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model," Circ. 92, 3025-3031 (1995).
40. T. A. Fischell, B. K. Kharma, D. R. Fischell, P G. Loges, C. W. Coffey II, D. M. Duggan, and A. J. Naftilan, "Low-dose, β-particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation," Circ 90, 2956-2963 (1994).
41. J. Gellman, G. Healey, C. Qingsheng, and M. J. Tselentakis, "The effect of very low dose irradiation on restenosis following balloon angioplasty. A study in the atherosclerotic rabbit," Circ. 84, 46A-59A (1991).
42. J. G. Wiedermann, C. Marboe, H. Amols, A. Schwartz, and J. Weinberger, "Intracoronary irradiation fails to reduce neointimal proliferation after oversized stenting in a porcine model," [Abstract] Circ. 92, I-146 (1995).
43. N. L. Eigler, M. J. Khorsandi, J. S. Forrester, M. C Fishbein, and F Litvack, "Implantation and recovery of temporary metallic stents in canine coronary arteries," J. Am. Coll Cardiol. 22(4), 1207-1213 (1993).
44. C. M. Lederer, J. M. Hollander, and I. Perlman Table of Isotopes (Wiley, New York, 1967)
45. C. G. Soares, "Calibration of ophthalmic applicators at NIST: A revised approach," Med. Phys. 18, 788-793 (1991).
46. P. J. Muench, A. S. Meigooni, and R. Nath, "Photon energy dependence of the sensitivity of radiochromic film and comparison with silver halide film and LiF TLDs used for brachytherapy dosimetry," Med. Phys. 18, 769-775 (1991)
47. S. T. Chiu-Tsao, A. de la Zerda, J. Lin, and J. H. Kim, "High-sensitivity GafChromic film dosimetry for 1-125 seed," Med. Phys. 21, 651-657 (1994).
48. MCNP-A General Monte Carlo N-Particle Transport Code [computer program]. Briesmeister JF, Version 4A (Radiation Shielding Information Center, Los Alamos NM. 1993); LA-12625-M.
49. W. V. Prestwich, T. J. Kennett, and F. W. Kus, "The dose distribution produced by a 32P-coated stent," Med. Phys. 22, 313-320 (1995).
50. D J. Simpkin and T. R. Mackie, "EGS4 Monte Carlo determination of the beta dose kernel in water," Med. Phys. 17, 179-186 (1990).
51. E. Browne and R. B. Firestone, Table of Radioactive Isotopes (Wiley, New York, 1986).
52. L T. Dillman and F. C. Von der Lage "Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation," MIRD Pamphlet No. 10 (Society of Nuclear Medicine, New York, 1975).
53. A. S. Meigooni, M. F. Sanders, G. S. Ibbott, and S. R. Szeglin, "Dosimetric characteristics of an improved radiochromic film," Med. Phys. 23, 1883-1888 (1996).
54. Bureau of Radiological Health, Radiological Health Handbook (U.S Government Printing Office, Washington, D.C., 1970), stock No. 017-011-00043-0.
55. Y Zhu, A. S. Kirov, V. Mishra, A. S. Meigooni, and J. F Williamson, "Quantitative evaluation of radiochromic film response for two-dimensional dosimetry," Med. Phys. 24, 223-231 (1997).